Genetic and Immunologic Basis of COVID-19 Infection

Official Title

Genetic Factors Influencing the Response to Infection With SARS-COV-2

Brief Summary

We will study genetic factors causing severe disease due to infection with SARS-COV-2 which may help to find targeted therapy

Status

Active, not recruiting

Conditions

Genetic Basis of COVID-19 Infection

Interventions

Diagnostic Test: Whole Exome Sequencing

Genetic study of patients

Eligibility Criteria

Inclusion Criteria:

- severe COVID-19 infection

Exclusion Criteria:

- Comorbidity ((DM, hypertension, Chronic liver or Kidney diseases, HIV, morbid obesity,
Malignancy, Immunosuppressive therapy)

Eligibility Gender

All

Eligibility Age

Minimum: 1 Day ~ Maximum: 50 Years

Countries

Egypt

Locations

Mansoura University
Mansoura, Dakahlyia, Egypt

NCT Number

NCT04384250

Keywords

SARS-COV-2, Genetics

MeSH Terms

Infections

Communicable Diseases

COVID-19

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Mansoura University

Genetic and Immunologic Basis of COVID-19 Infection

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA